OptionalRegionHeading_Programs

PUBLISHED ABSTRACTS

DiDomenico, D., Brown, J., Shaw, M., Sharifi, R., Ray, V., Rubenstein, M. and Guinan, P.: The effect of androgen deprivation on malignant and benign prostate tissue. J. Urol. 122a, 1997.

DiDomenico, D., Brown, J., Shaw, M., Rubenstein, M. and Guinan, P.: Intralesional AD-32 is efficacious in a prostate cancer model. Proceedings AACR 37:303a, 1996.

Frank, W., Shaw, M., Chet, A., Rubenstein, M. and Guinan, P.: BCG treatment increases PGF2 levels in Dunning AT-3 prostate murine tumor. Proceedings AACR 39:586a, 1998.

Guinan, P., Rubenstein, M., Shaw, M., McKiel, C.F. and Elterman, L.: African-Americans receive therapy for cure of prostate cancer at rates similar to whites. J. Urol. 161:357a, 1999.

Guinan, P., Shott, S., Sharifi, R., Kennedy, J., Ray, V;, Shaw, M. and Rubenstein, M.: Predicting response in hormone downstaged patients prior to radical prostatectomy. Proceedings AACR 39:15a, 1998.

Lievano, G., Rubenstein, M., Shaw, M. and Guinan, P.: Bropirimine as neoadjuvant therapy is effective in a prostate cancer model. J. Urol. 155:356a, 1996.

Rubenstein, M., Mirochnik, Y. and Guinan, P.:Enhanced cellular uptake and use of specific delivery vehicles in treating prostate cancer with antisense oligonucleotides. Proceedings AACR 42:377a, 2001.

Rubenstein, M., Mirochnik, Y., McKiel, C.F. and Guinan, P.: Evaluation of PSA and PSMA as targets for specific delivery of antisense oligonucleotides to LNCaP prostate tumor cells utilizing two monoclonal antibody derived vehicles. BJU International 86:Supplement 64a, 2000.

Rubenstein, M., Glick, R., Lichtor, T., Mirochnik, Y. and Guinan, P.: Decreased EGFR expression and growth of the human derived T98G glioblastoma following treatment with antisense oligonucleotides directed against EGFR. Proceedings AACR 41:644a, 2000.

Rubenstein, M., Mirochnik, Y. and Guinan, P.: Delivery of antisense oligonucleotides to prostate cancer by monoclonal vehicles in in vivo and in vitro models. Proceedings AACR 40:586a, 1999.

Rubenstein, M., Shaw, M.W., Slobodskoy, L., Mirochnik, Y., Glick, R., Lichtor, T., Shaw, M.M., Robertson, N., Garcia, V., Frazier, L. and Guinan, P.: Establishment of the T98G glioblastoma tumor in athymic nude mice utilizing Matrigel and orthotopic implantation. Proceedings AACR 40:717a, 1999.

Rubenstein, M., Mirochnik, Y. and Guinan, P.: Specific delivery of oligonucleotides to prostate tumors utilizing two monoclonal antibody derived vehicles. Eur. Urol. 36:516a, 1999.

Rubenstein, M., Glick, R., Lichtor, T., Mirochnik, Y. and Guinan, P.: Dose response and cellular uptake of antisense oligonucleotides to transforming growth factor- and the epidermal growth factor receptor of the T98G glioblastoma. Proceedings AACR 39:416a, 1998.

Rubenstein, M., Glick, R., Lichtor, T., Mirochnik, Y. and Guinan, P.: Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed towards mRNA encoding transforming growth factor-a and the epidermal growth factor receptor. Proceedings AACR 38:10a, 1997.

Rubenstein, M., Mirochnik, Y., McKiel, C.F. and Guinan, P.: Antisense oligonucleotide intralesional therapy of human PC-3 prostate tumors carried in athymic nude mice. J. Urol. 155:602a, 1996.

Rubenstein, M., Mirochnik, Y. and Guinan, P.: Delivery of biotinylated agents to prostate cancer cells utilizing hybrid monoclonal antibodies. Proceedings AACR 37:303a, 1996.

Rubenstein, M., Mirochnik, Y. and Guinan, P.: Growth factor deprivation therapy of hormone insensitive breast cancer utilizing antisense oligonucleotides. Cancer Detect. and Prevent. 20:430a, 1996.

Rubenstein, M., Sharifi, R., Ray, V., Lievano, G., Mirochnik, Y., Shaw, M. and Guinan, M.: Androgen blockade prior to radical prostatectomy: Can response be predicted? Cancer Detect. and Prevent. 20:515a, 1996.

Rubenstein, M., Sharifi, R., Ray, V., Lievano, G., Mirochnik, Y., Shaw, M. and Guinan, P.: Radical prostatectomy after androgen blockade: Are marker and morphologic changes significant? Cancer Detect. and Prevent. 20:516a, 1996.

Streisand, S., Shaw, M., Rubenstein, M. and Guinan, P.: African-Americans are not receiving treatment for cure for prostate cancer at rates comparable to white. J. Urol. 163:290a, 2000.

Uzoaru, I., Rubenstein, M. and Guinan, P.: Histologic, proliferative and karyotypic evaluation of 42 patients with stage IV prostate cancer. Proceedings AACR 38:542a, 1997.